1. Statutory Text and Purpose in Substantive Criminal Law
Section 276 of the Bharatiya Nyaya Sanhita, 2023 (BNS) stands at the head of the three-section pharmaceutical integrity cluster (Sections 276, 277, and 278) in Chapter XV (Of Offences Affecting the Public Health, Safety, Convenience, Decency and Morals) S1, s. 276. The enacted Gazette text provides verbatim:
276. Adulteration of drugs.—Whoever adulterates any drug or medical preparation in such a manner as to lessen the efficacy or change the operation of such drug or medical preparation, or to make it noxious, intending that it shall be sold or used for, or knowing it to be likely that it will be sold or used for, any medicinal purpose, as if it had not undergone such adulteration, shall be punished with imprisonment of either description for a term which may extend to one year, or with fine which may extend to five thousand rupees, or with both. S1, s. 276
Whereas Sections 274 and 275 BNS address food and drink, Sections 276 to 278 BNS govern the criminal adulteration, sale of adulterated, and mislabelled dispensing of drugs and medical preparations S1, ss. 274–278. The threshold of physical alteration required to trigger criminal liability under Section 276 BNS (drugs) is significantly broader than under Section 274 BNS (food or drink). To commit food adulteration under Section 274 BNS, the adulteration must render the food or drink affirmatively noxious (injurious to health) S1, s. 274. By contrast, under Section 276 BNS, a person commits the offence of drug adulteration not only when the drug is rendered noxious, but also when the adulteration merely lessens the efficacy or changes the operation of the drug or medical preparation S1, s. 276. In substantive criminal law, this reflects the principle that a diluted or chemically altered medicine that fails to cure a patient, or operates differently than expected by a prescribing physician, poses a grave threat to human life and public health even if the diluent itself (such as distilled water or chalk powder) is biologically harmless.
2. Exact Offence Ingredients and Mental Element (Mens Rea)
To establish guilt under Section 276 BNS, the prosecution must prove three cumulative components beyond reasonable doubt S1, s. 276:
- The Act of Adulteration (Actus Reus: Conduct and Subject Matter):
- The accused must adulterate (mix with foreign, inferior, or unauthorized substances, dilute, or abstract active constituents from) a drug or medical preparation S1, s. 276.
- Although the BNS does not contain an internal definition of "drug" or "medical preparation" in Section 2, the expression encompasses any substance or compound used internally or externally for the diagnosis, treatment, mitigation, or prevention of disease or disorder in human beings, consistent with the expansive judicial understanding of medicinal preparations articulated by the Supreme Court in Chimanlal Jagjivandas Sheth v. State of Maharashtra, AIR 1963 SC 665 S1, s. 2; S7, paras 6–10.
- The Qualitative Effect on the Drug (Actus Reus: Result Requirement):
- The adulteration must be carried out in such a manner as to produce at least one of three alternative effects on the drug or medical preparation S1, s. 276:
- (a) Lessen its efficacy (e.g., reducing the potency or active pharmaceutical ingredient concentration so the medicine works more weakly or slowly);
- (b) Change its operation (e.g., altering its chemical profile, release rate, or physiological action); or
- (c) Make it noxious (rendering the preparation toxic, contaminated, or harmful to health).
- Actual consumption by, or bodily injury to, a patient is not an ingredient of Section 276 BNS; the offence is complete at the stage of adulteration once accompanied by the requisite mental state S1, s. 276.
- The adulteration must be carried out in such a manner as to produce at least one of three alternative effects on the drug or medical preparation S1, s. 276:
- The Dual Mental Element (Mens Rea: Intention or Knowledge of Likely Deceptive Medicinal Use):
- Section 276 BNS is not a strict-liability offence. Beyond the conscious act of adulteration, the statute requires a specific ulterior mental state: the accused must act either intending that the drug shall be sold or used for, or knowing it to be likely that it will be sold or used for, any medicinal purpose, as if it had not undergone such adulteration S1, s. 276.
- Notice the twin facets of this mental standard:
- First, it covers both purposeful intention (where the manufacturer adulterates the batch to sell it) and cognitive foresight of likelihood ("knowing it to be likely" that downstream distributors or compounders will sell or use it medicinally) S1, s. 276.
- Second, the phrase "as if it had not undergone such adulteration" is legally decisive S1, s. 276. If a pharmacist dilutes a potent tincture specifically for a pediatric prescription and labels it accurately as a diluted preparation so that it is used as a diluted preparation rather than as if unadulterated, the offence under Section 276 BNS is not committed.
- Furthermore, by virtue of Section 3(1) BNS, Section 276 is read subject to Chapter III (General Exceptions), including mistake of fact in good faith (Sections 14 and 17 BNS) and accident in doing a lawful act with proper care and caution (Section 18 BNS) S1, ss. 3(1), 14, 17, 18.
3. IPC-to-BNS Correspondence and Statutory Changes
Section 276 BNS directly replaces Section 274 of the Indian Penal Code, 1860 (IPC) S4, s. 274; S5. While retaining the core offence structure, Parliament enacted one grammatical clarification and two substantive enhancements in punishment S1, s. 276; S4, s. 274:
| Attribute | IPC Section 274 (Repealed w.e.f. 01-07-2024) | BNS Section 276 (Effective 01-07-2024) | Legal & Practical Significance |
|---|---|---|---|
| Section Number & Heading | Section 274: Adulteration of drugs. S4, s. 274 | Section 276: Adulteration of drugs. S1, s. 276 | Renumbered within Chapter XV of the BNS S5. |
| Wording of Deceptive Use Clause | "...as it had not undergone such adulteration..." S4, s. 274 | "...as if it had not undergone such adulteration..." S1, s. 276 | Inserts the conjunction "if" to modernize archaic 1860 syntax without altering the substantive ingredient S1, s. 276; S4, s. 274. |
| Maximum Imprisonment | Imprisonment of either description up to six months S4, s. 274 | Imprisonment of either description up to one year S1, s. 276 | Doubled maximum custodial sentence (from 6 months to 1 year), raising the penal gravity of upstream drug adulteration above retail sale under Section 277 BNS (which remains 6 months) S1, ss. 276, 277. |
| Maximum Fine | Up to ₹1,000 ("one thousand rupees") S4, s. 274 | Up to ₹5,000 ("five thousand rupees") S1, s. 276 | Five-fold increase in statutory fine ceiling S1, s. 276; S4, s. 274. |
| Default-of-Fine Imprisonment Cap | Up to 1.5 months (one-fourth of 6 months under Section 65 IPC) S4, s. 65 | Up to 3 months (one-fourth of 1 year under Section 8(3) BNS) S1, s. 8(3) | Because maximum imprisonment doubled to 1 year, the maximum imprisonment in default of payment of fine under Section 8(3) BNS correspondingly increases to 3 months S1, s. 8(3). |
Note on State Amendments: Under the IPC regime, certain states: most notably Uttar Pradesh (vide U.P. Act 47 of 1975) and West Bengal (vide W.B. Act 42 of 1973): had amended Section 274 IPC to make drug adulteration punishable with imprisonment for life and cognizable/non-bailable. With the repeal of the IPC under Section 358(1) BNS on 1 July 2024, the central text of Section 276 BNS governs post-commencement conduct unless and until a state enacts and receives Presidential assent (under Article 254(2) of the Constitution) for a corresponding state amendment to the BNS and BNSS S1, s. 358.
4. Punishment Matrix and Sentencing Mechanics
Under Section 276 BNS, a convict is liable to three alternative sentencing modes ("shall be punished with imprisonment... or with fine... or with both") S1, s. 276:
- Imprisonment: Up to one year (no mandatory minimum term). Because it is "imprisonment of either description," the sentencing Magistrate has discretion under Section 7 BNS to direct that the sentence be wholly rigorous, wholly simple, or partly rigorous and partly simple S1, ss. 7, 276.
- Fine: Discretionary, up to ₹5,000 S1, s. 276.
- Imprisonment in Default of Payment of Fine: Because Section 276 is punishable with imprisonment as well as fine, Section 8(3) BNS caps any imprisonment imposed in default of payment of fine at one-fourth of the maximum term fixed for the offence, that is, three months (of either description, per Section 8(4) BNS) S1, s. 8(3)–(4). If the offender is sentenced to a fine only, Section 8(3) BNS still governs because the offence itself is punishable with imprisonment as well as fine S1, s. 8(2)(a), 8(3).
5. Procedural Classification (BNSS 2023) and Special-Law Overlap
A. BNSS First Schedule and Summary Trial
Under the First Schedule to the Bharatiya Nagarik Suraksha Sanhita, 2023 (BNSS), the procedural parameters for Section 276 BNS are S2, First Schedule:
- Cognizability: Non-cognizable. A police officer cannot arrest without a warrant and, under Section 174(2) BNSS (formerly Section 155(2) CrPC), cannot investigate a standalone offence under Section 276 BNS without an order of a Magistrate having power to try such case or commit the case for trial S2, s. 174, First Schedule.
- Bailability: Bailable as of right under Section 478 BNSS S2, First Schedule.
- Triable Court: Any Magistrate S2, First Schedule.
- Summary Trial: Even though general summary trial eligibility under Section 283(1) BNSS applies to offences not punishable with imprisonment exceeding three years, Section 283(1)(i) BNSS expressly enumerates "offences under section 276 or section 277 of the Bharatiya Nyaya Sanhita, 2023" as triable summarily by a Chief Judicial Magistrate or any Judicial Magistrate of the first class S2, s. 283(1)(i).
- Compoundability: Non-compoundable; Section 276 BNS is absent from both tables of Section 359 BNSS S2, s. 359.
B. Interaction with the Drugs and Cosmetics Act, 1940
In contemporary practice, drug adulteration is heavily regulated by a special statute: the Drugs and Cosmetics Act, 1940 (specifically Section 17A defining "adulterated drugs" and Section 27 prescribing stringent penalties, up to life imprisonment where an adulterated drug is likely to cause death or grievous hurt) S6. Under Section 1(6) BNS and Section 5 BNSS, nothing in the BNS or BNSS affects the provisions of any special law S1, s. 1(6); S2, s. 5.
In the landmark decision of Union of India v. Ashok Kumar Sharma & Ors., (2021) 12 SCC 674 (decided 28 August 2020), the Supreme Court authoritatively resolved the procedural interplay between general penal provisions and Chapter IV of the Drugs and Cosmetics Act, 1940 S6, paras 150–170:
- For offences falling exclusively under Chapter IV of the Drugs and Cosmetics Act, 1940, Section 32 of that Act bars prosecution except by a Drugs Inspector or other statutorily authorized person/aggrieved person, and police officers have no power to register an FIR or investigate under general criminal procedure S6, paras 150–162.
- However, where the facts also disclose distinct cognizable offences under other laws or the general penal code, police investigation into those distinct cognizable offences is not barred, though the police cannot circumvent Section 32 of the 1940 Act merely by dressing up a pure Drugs and Cosmetics Act violation in penal code provisions S6, paras 163–170. Because Section 276 BNS is itself non-cognizable under the BNSS First Schedule, a police officer cannot register a standalone FIR under Section 276 BNS without a Magistrate's order under Section 174(2) BNSS S2, s. 174, First Schedule; S6.
6. Temporal Applicability and Constitutional Retrospectivity
Section 276 BNS entered into force on 1 July 2024 pursuant to MHA Notification S.O. 850(E) dated 23 February 2024 S3. Under Section 358(2) BNS and Article 20(1) of the Constitution of India:
- If the act of adulterating a drug was completed before 1 July 2024, the prosecution must proceed under Section 274 IPC, and the court cannot impose the enhanced BNS punishment (1 year imprisonment or ₹5,000 fine), as Article 20(1) strictly prohibits subjecting any person to a penalty greater than that which might have been inflicted under the law in force at the time of the commission of the offence S1, s. 358(2); S4, s. 274.
- If the act of adulteration occurs on or after 1 July 2024, or if a continuing batch-adulteration operation continues on or after 1 July 2024, Section 276 BNS applies in full S1, ss. 276, 358; S3.
7. Practical Illustrations and Counterexamples
- Editorial Hypothetical 1 (Lessened Efficacy Without Toxicity: Offence Committed): A, an unlicensed compounder, mixes 40% inert starch into a batch of life-saving antibiotic capsules to stretch his inventory, knowing that local clinics will purchase and administer the capsules to patients as standard full-strength antibiotics. Even though inert starch is non-toxic (not "noxious"), A has lessened the efficacy of the drug with knowledge that it is likely to be used for a medicinal purpose as if unadulterated. A is liable under Section 276 BNS S1, s. 276.
- Editorial Hypothetical 2 (Changed Operation: Offence Committed): B crush-grinds enteric-coated extended-release cardiac tablets and repackages the powder into plain gelatin capsules for sale as the original formulation. Because destroying the enteric coating changes the physiological operation and absorption rate of the preparation, and B intends it to be sold as if unaltered, B commits the offence under Section 276 BNS S1, s. 276.
- Editorial Counterexample (Transparent Compounding / No Deceptive Use: No Offence): C, a hospital pharmacist, dilutes a concentrated antiseptic solution to a 1% pediatric wash in accordance with a physician's order and clearly labels the bottle "Diluted 1% Solution — Not Full Strength." Although the concentration was reduced, C neither intended nor knew it to be likely that the preparation would be sold or used as if it had not undergone such dilution. Section 276 BNS is not attracted S1, s. 276.